Cite
HARVARD Citation
Ader, F. et al. (2021). An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clinical microbiology and infection. pp. 1826-1837. [Online].